GlassScriptPhysician profile
Saurabh Joshi
NPI 1891040606
$8,447.68
in general payments reported to CMS, 2019-2025
22 companies · $2,557 in 2025
The $2,557 reported for 2025 was more than what a typical Interventional Cardiology provider received nationally (typical 2025 total: $1,092).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $2,538 · 2020: $1,212 · 2021: $447 · 2022: $378 · 2023: $74.87 · 2024: $1,243 · 2025: $2,557.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $2,555 · Travel and Lodging: $1,319.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $2,555.40 |
| Travel and Lodging | $1,318.88 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Boston Scientific Corporation | $2,520.38 | 2019-2024 | Avvigo Guidance System |
| Abbott Laboratories | $2,400.83 | 2019-2025 | Cardiomems, Supera, Xience Skypoint |
| Edwards Lifesciences Corporation | $1,146.99 | 2020 | |
| Shockwave Medical, INC | $764.45 | 2025 | |
| Medtronic, INC. | $281.39 | 2024-2025 | Aurora Ev-Icd Mri Surescan, Symplicity G3 |
| Cardiovascular Systems INC. | $246.13 | 2021-2022 | |
| Inquis Medical, INC. | $244.76 | 2025 | Aventus |
| Terumo Medical Corporation | $194.85 | 2021-2024 | Glidesheath Slender |
| Astrazeneca Pharmaceuticals LP | $145.28 | 2019-2022 | |
| Opsens INC. | $103.27 | 2021-2022 | |
| Chiesi USA, INC. | $73.22 | 2021-2024 | Kengreal |
| Medtronic Vascular, INC. | $58.96 | 2019 | |
| Cardiva Medical, INC. | $51.91 | 2024 | Savvywire, Optowire |
| Philips North America LLC | $35.32 | 2025 | Coronary Other |
| Inari Medical, INC. | $34.40 | 2024 | Ct Thrombectomy System Kit, Flowtriever Catheter, S |
Show all 22 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Janssen Pharmaceuticals, INC | $32.39 | 2019-2022 | |
| Amgen INC. | $23.67 | 2020 | |
| Penumbra, INC. | $20.25 | 2023 | Indigo System |
| Zoll Services LLC (A/K/A Zoll Lifecor Corp) | $19.56 | 2019 | |
| Boehringer Ingelheim Pharmaceuticals, INC. | $18.82 | 2024 | Jardiance |
| Merck Sharp & Dohme LLC | $17.88 | 2022 | |
| Ge Healthcare | $12.97 | 2021 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Saurabh Joshi listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.